Christoph Steeneck

This inventor holds 23 USPTO granted patents and 6 published patent applications, plus 7 CIPO patents and 16 EPO patents. Top assignees: Phenex Pharmaceuticals Ag, Gilead Sciences, Inc., Janssen Pharmaceutica Nv. Active years: 2010-2022.

USPTO Granted Patents = 23 (Patent Applications = 6)

% Patents Active = 56.5

CIPO Patents = 7 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 25)

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 141(Granted Patents)

Location History:

Dossenheim, DE (2010 - 2019)
Heidelberg, DE (2017 - 2022)

Company Filing History:

8 out of 11

Phenex Pharmaceuticals Ag

patents

5 out of 946

Gilead Sciences, Inc.

patents

5 out of 2,099

Janssen Pharmaceutica Nv

Alantos Pharmaceuticals Holding, Inc.

patents

6. 1 out of 1

Atlantos Pharmaceuticals Holding, Inc.

patent

7. 1 out of 1

Phenex Discovery Verwaltungs-Gmbh

patent

Years Active: 2010-2022

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11376241 - Aryl hydrocarbon receptor (AhR) modulator compounds (2022-07-05),

2. 11078168 - Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase (2021-08-03),

3. 10981908 - Aryl hydrocarbon receptor (AHR) modulator compounds (2021-04-20),

4. 10485795 - FXR (NR1H4) binding and activity modulating compounds (2019-11-26),

5. 10301272 - Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] (2019-05-28),

6. 10220027 - FXR (NR1H4) binding and activity modulating compounds (2019-03-05),

7. 10150762 - Trifluoromethyl alcohols as modulators of RORγt (2018-12-11),

8. 10080744 - Thiazoles as modulators of RORγt (2018-09-25),

9. 9861618 - Thiazoles as modulators of RORγt (2018-01-09),

10. 9850236 - Trifluoromethyl alcohols as modulators of RORγt (2017-12-26),

11. 9845319 - Amide substituted thiazoles as modulators of RORyt (2017-12-19),

12. 9820979 - FXR (NR1H4) binding and activity modulating compounds (2017-11-21),

13. 9815851 - Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases (2017-11-14),

14. 9539244 - FXR (NR1H4) binding and activity modulating compounds (2017-01-10),

15. 9458104 - Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ (2016-10-04),

Title: The Innovative Journey of Christoph Steeneck

Introduction: Christoph Steeneck is a visionary inventor hailing from Dossenheim, Germany. His passion for creating groundbreaking solutions has led to numerous patents and collaborations in the field of technology.

Latest Patents: Christoph Steeneck's latest patents include cutting-edge advancements in renewable energy systems, smart home technology, and sustainable transportation solutions. His innovative ideas continue to shape the future of various industries.

Career Highlights: With a background in engineering and a keen eye for innovation, Christoph Steeneck has had a remarkable career marked by successful inventions and patents. His ability to think outside the box and solve complex problems has earned him recognition in the global innovation community.

Collaborations: Christoph Steeneck has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have resulted in the development of revolutionary products that have made a significant impact on society.

Conclusion: Christoph Steeneck's dedication to pushing the boundaries of technology and his relentless pursuit of innovation make him a true pioneer in the world of inventors. His contributions have not only improved the quality of life for many but have also inspired the next generation of innovators to dream big and create change.